GRDG utilizes proprietary bio-informatic logarithmic protocols for rapid identification and determination of potential therapeutic agents addressing a wide range of disease categories. Our team is continually investigating promising compounds that can quickly be identified as useful therapeutic treatments.

GRDG's current areas of focus include:

-Neurological -Cancer -Metabolic Disorders -Cardiac Myopathy -Skin Disorders -Chronic Inflammation -Retroviral / Influenza migration limiting applications -Medical Foods -Veterinary Applications -Agriculture / Pharmaceutical Pharming -Pharmaceutical Delivery Vehicles